Intermittent rifampicin treatment.
D000995:Antitubercular Agents / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D005387:Finland; D006801:Humans; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy
D000995:Antitubercular Agents; D012293:Rifampin